<DOC>
	<DOCNO>NCT01418989</DOCNO>
	<brief_summary>This open-label , multi-center study compare bioavailability RoActemra/Actemra ( tocilizumab ) administration auto-injector versus pre-filled syringe healthy volunteer . Healthy volunteer receive single dose RoActemra/Actemra ( tocilizumab ) . The anticipated time study duration 28 day .</brief_summary>
	<brief_title>A Study Administration RoActemra/Actemra ( Tocilizumab ) Auto-injector Vs. Pre-filled Syringe Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy volunteer , age 18 65 year inclusive Intact normal skin without potentially obscure tattoo , pigmentation , lesion area intend injection A body mass index ( BMI ) 18 32 kg/m2 inclusive Volunteers know active current history recurrent bacterial , viral , fungal , mycobacterial infection A history clinically significant gastrointestinal , renal , hepatic , cardiovascular , allergic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>